| 臺大學術典藏 |
2021-09-01T01:54:03Z |
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3
|
Tai W.-T.; ANN-LII CHENG; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; Chen P.-J.; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:54:02Z |
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer
|
Kuo W.-H.; Lin P.-H.; Huang A.-C.; Chien Y.-H.; Liu T.-P.; Lu Y.-S.; Bai L.-Y.; Sargeant A.M.; Lin C.-H.; ANN-LII CHENG; Hsieh F.-J.; Hwu W.-L.; Chang K.-J. |
| 臺大學術典藏 |
2021-09-01T01:54:02Z |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
|
Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:02Z |
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
|
Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu C.; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
The impact of diabetes mellitus on prognosis of early breast cancer in Asia
|
Chen W.-W.; Shao Y.-Y.; Shau W.-Y.; Lin Z.-Z.; Lu Y.-S.; Chen H.-M.; Kuo R.N.C.; ANN-LII CHENG; Lai M.-S. |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A
|
Huang C.-Y.; Wei C.-C.; Chen K.-C.; Chen H.-J.; ANN-LII CHENG; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: A novel approach by using meta-regression
|
Shen Y.-C.; Hsu C.; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:00Z |
The emerging epidemic of estrogen-related cancers in young women in a developing Asian country
|
Lin C.-H.; Chen Y.-C.; Chiang C.-J.; Lu Y.-S.; Kuo K.-T.; Huang C.-S.; Cheng W.-F.; Lai M.-S.; You S.-L.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:00Z |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
|
Kuo S.-H.; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Hsu P.-N.; Wang H.-P.; Chen L.-T.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:59Z |
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression
|
Hsu C.; Shen Y.-C.; Cheng C.-C.; ANN-LII CHENG; Hu F.-C.; Yeh K.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:59Z |
CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells
|
Lin Y.-C.; Chen K.-C.; Chen C.-C.; ANN-LII CHENG; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:53:59Z |
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial
|
ANN-LII CHENG; Guan Z.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Yang T.-S.; Tak W.Y.; Pan H.; Yu S.; Xu J.; Fang F.; Zou J.; Lentini G.; Voliotis D.; Kang Y.-K. |
| 臺大學術典藏 |
2021-09-01T01:53:59Z |
Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma
|
Lu Y.-S.; Chou C.-H.; Tzen K.-Y.; Gao M.; ANN-LII CHENG; Kulp S.K.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:58Z |
Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling
|
Kuo S.-H.; Chou C.-H.; ANN-LII CHENG; Wang C.-W.; Chen Y.-H.; Chen R.-J. |
| 臺大學術典藏 |
2021-09-01T01:53:58Z |
Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy
|
Shao Y.-Y.; Huang C.-C.; Lin S.-D.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:58Z |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; Hsu C.; ANN-LII CHENG; Lai M.-S. |
| 臺大學術典藏 |
2021-09-01T01:53:57Z |
Primary squamous cell carcinoma of the thyroid with cardiac metastases and right ventricle outflow tract obstruction
|
Chen K.-H.; Chou Y.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:57Z |
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
|
Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:57Z |
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer
|
Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; Hsu C.; Cheng W.-F.; Lin Y.-L.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:57Z |
Non-bacterial infections in Asian patients treated with alemtuzumab: A retrospective study of the Asian Lymphoma Study Group
|
Kim S.J.; Moon J.H.; Kim H.; Kim J.S.; Hwang Y.Y.; Intragumtornchai T.; Issaragrisil S.; Kwak J.Y.; Lee J.J.; Won J.H.; Reksodiputro A.H.; Lim S.T.; ANN-LII CHENG; Kim W.S.; Kwong Y.L. |
| 臺大學術典藏 |
2021-09-01T01:53:56Z |
Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma
|
Shao Y.-Y.; Chen C.-L.; Ho M.-C.; Huang C.-C.; Tu H.-C.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:56Z |
BCL10GFP fusion protein as a substrate for analysis of determinants required for Mucosa-Associated Lymphoid Tissue 1 (MALT1)-mediated cleavage
|
Jou S.-Y.; Chang C.-C.; Wu C.-H.; Chen M.-R.; Tsai C.-H.; Chuang W.-H.; Chen Y.-H.; ANN-LII CHENG; Doong S.-L. |
| 臺大學術典藏 |
2021-09-01T01:53:56Z |
Medulloblastoma in adults: Treatment outcome, relapse patterns, and prognostic factors
|
Lai S.-F.; Wang C.-W.; Chen Y.-H.; Lan K.-H.; Cheng J.C.-H.; ANN-LII CHENG; Kuo S.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:56Z |
Management of colon cancer: Resource-stratified guidelines from the Asian Oncology Summit 2012
|
Ku G.; Tan I.B.; Yau T.; Boku N.; Laohavinij S.; ANN-LII CHENG; Kang Y.-K.; de Lima Lopes G. |
